2015 ◽
Vol 6
(5)
◽
pp. 228-241
◽
Sarah K. Tasian
◽
Rebecca A. Gardner
2019 ◽
Vol 25
(3)
◽
pp. 191-198
◽
Francesco Ceppi
◽
Rebecca A. Gardner
2019 ◽
Vol 33
(11)
◽
pp. 2751-2753
◽
Jiang Cao
◽
Hai Cheng
◽
Ming Shi
◽
Gang Wang
◽
Wei Chen
◽
...
2018 ◽
Vol 67
(4)
◽
pp. 533-540
◽
Jae H Park
◽
F Andres Romero
◽
Ying Taur
◽
Michel Sadelain
◽
Renier J Brentjens
◽
...
2020 ◽
Vol 20
(6)
◽
pp. 366-370
◽
Xiaojuan Chen
◽
Ying Wang
◽
Min Ruan
◽
Jun Li
◽
Mengjun Zhong
◽
...
Ciprian Tomuleasa
◽
Shigeo Fuji
◽
Cristian Berce
◽
Anca Onaciu
◽
Sergiu Chira
◽
...
2014 ◽
Vol 16
(4)
◽
pp. S8
M. Ruella
◽
O. Shestova
◽
S. Kenderian
◽
D. Barrett
◽
S. Grupp
◽
...
2018 ◽
Vol 6
(11)
◽
pp. 235-235
◽
2021 ◽
Vol 27
(2)
◽
pp. 98-106
Jordan Gauthier
◽
Cameron J. Turtle
2020 ◽
Vol 16
(6)
◽
pp. 1356-1358
Fang Liu
◽
Sha Sha
◽
Gina Ma
◽
Yi Su
◽
Yisong Xiong
◽
...
Close
Export Citation Format
Close
Share Document
Close
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)
